Backstageplay Inc.
Backstageplay Inc. (PRYNF) Financial Performance & Income Statement Overview
Explore the financials of Backstageplay Inc. (PRYNF), including yearly and quarterly data on income, cash flow, and balance sheets.
Backstageplay Inc. (PRYNF) Income Statement & Financial Overview
Analyze Backstageplay Inc.’s PRYNF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $4.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $4.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $40250.00 | $39508.00 | $8750.00 | $11425.00 |
| Operating Expenses | $70556.00 | $50620.00 | $17139.00 | -$19853.00 |
| Total Costs & Expenses | $70556.00 | $50620.00 | $17139.00 | -$19853.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$39444.00 |
| EBITDA | -$70269.00 | -$50620.00 | -$16868.00 | -$19591.00 |
| EBITDA Ratio | $0.00 | $0.00 | -$3924.77 | $0.00 |
| Operating Income | -$70556.00 | -$50620.00 | -$17139.00 | $19853.00 |
| Operating Income Ratio | $0.00 | $0.00 | -$3987.83 | $0.00 |
| Other Income/Expenses (Net) | $0.00 | -$226.00 | -$25.00 | -$39706.00 |
| Income Before Tax | -$70556.00 | -$50846.00 | -$17156.00 | -$19853.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | -$3991.78 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$70556.00 | -$50846.00 | -$17156.00 | -$19853.00 |
| Net Income Ratio | $0.00 | $0.00 | -$3991.78 | $0.00 |
| EPS | -$3.03 | -$0.005 | -$0.83 | -$1.00 |
| Diluted EPS | -$3.03 | -$0.005 | -$0.83 | -$0.96 |
| Weighted Avg Shares Outstanding | $23313.00 | $20688.00 | $20688.00 | $19852.00 |
| Weighted Avg Shares Outstanding (Diluted) | $23313.00 | $20688.00 | $20688.00 | $20687.00 |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q2 2024 to $0.00 in Q1 2025. Gross profit remained healthy with margins at N/A in Q1 2025 compared to N/A in Q2 2024. Operating income hit -$70556.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$70269.00. Net income dropped to -$70556.00, while earnings per share reached -$3.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan